These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33318000)

  • 1. The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa.
    Wang G; Brunel JM; Bolla JM; Van Bambeke F
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane.
    Wang G; Brunel JM; Rodriguez-Villalobos H; Bolla JM; Van Bambeke F
    Eur J Med Chem; 2022 Aug; 238():114496. PubMed ID: 35691172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence.
    Wang G; Brunel JM; Preusse M; Mozaheb N; Willger SD; Larrouy-Maumus G; Baatsen P; Häussler S; Bolla JM; Van Bambeke F
    Commun Biol; 2022 Aug; 5(1):871. PubMed ID: 36008485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the efflux pump-mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor.
    Tohidpour A; Najar Peerayeh S; Mehrabadi JF; Rezaei Yazdi H
    Curr Microbiol; 2009 Sep; 59(3):352-5. PubMed ID: 19554368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
    Lamers RP; Cavallari JF; Burrows LL
    PLoS One; 2013; 8(3):e60666. PubMed ID: 23544160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes.
    Buyck JM; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2013 May; 57(5):2310-8. PubMed ID: 23478951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
    Buyck JM; Peyrusson F; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4750-8. PubMed ID: 26014952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    Sonnet P; Izard D; Mullié C
    Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
    BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii.
    Cortez-Cordova J; Kumar A
    Int J Antimicrob Agents; 2011 May; 37(5):420-4. PubMed ID: 21377839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
    Laudy AE; Kulińska E; Tyski S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains.
    Ferrer-Espada R; Shahrour H; Pitts B; Stewart PS; Sánchez-Gómez S; Martínez-de-Tejada G
    Sci Rep; 2019 Mar; 9(1):3452. PubMed ID: 30837499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimeric Rifampicin-Tobramycin conjugates break intrinsic resistance of Pseudomonas aeruginosa to doxycycline and chloramphenicol in vitro and in a Galleria mellonella in vivo model.
    Idowu T; Arthur G; Zhanel GG; Schweizer F
    Eur J Med Chem; 2019 Jul; 174():16-32. PubMed ID: 31022550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of ceftazidime/avibactam against extracellular and intracellular forms of Pseudomonas aeruginosa.
    Buyck JM; Luyckx C; Muccioli GG; Krause KM; Nichols WW; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2017 May; 72(5):1400-1409. PubMed ID: 28137941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
    Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria.
    Piddock LJ; Garvey MI; Rahman MM; Gibbons S
    J Antimicrob Chemother; 2010 Jun; 65(6):1215-23. PubMed ID: 20304975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of antibiotics plus efflux pump inhibitors on mutant selection window of Pseudomonas aeruginosa in vitro].
    Xu L; Liu M; Zhang Y; Qi Q; Li Y
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(26):2055-8. PubMed ID: 25312669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.